Michaela Ann Dinan | Scholars@Duke

Michaela Ann Dinan
Assistant Professor in Population Health Sciences

Dr. Dinan is a health services researcher with a focus on emerging medical technology in cancer. Dr. Dinan currently holds an AHRQ K99/R00 pathway to independence award to examine adoption of Oncotype DX molecular testing in breast cancer and has conducted work in breast and other cancers examining emerging technologies and their associated disparities in utilization, outcomes and costs. Dr. Dinan has expertise in both secondary data analysis and clinical registry methodologies. Her secondary data expertise include the SEER-Medicare linked data, Medicare claims, NIS, NCDB, as well as EHR data.

Dr. Dinan holds additional appointments at the Duke Clinical Research Institute and Duke Cancer Institute where she co-leads the Patient Experience and Survivorship Focus Area in the Cancer Control and Population Sciences Program.

Areas of expertise: Health Economics, Health Policy, and Health Services Research

Current Appointments & Affiliations

Assistant Professor in Population Health Sciences, Population Health Sciences, Basic Science Departments 2017
Assistant Professor in Medicine, Medicine, Medical Oncology, Medicine 2018
Member of the Duke Cancer Institute, Duke Cancer Institute, Institutes and Centers 2013
Membership in the Duke Clinical Research Institute, Duke Clinical Research Institute, Institutes and Centers 2013

Contact Information

2200 West Main Street Suite 720-A, Durham, NC 27705
Duke Box 104023, Durham, NC 27710
michaela.dinan@duke.edu (919) 668-8177

Background
Education, Training, & Certifications
- Ph.D., University of North Carolina at Chapel Hill 2011
- B.S., University of Virginia 2003
Duke Appointment History
- Assistant Professor in Medicine, Medicine, Medical Oncology, Medicine 2015 - 2017
- Medical Instructor in the Department of Medicine, Medicine, Medical Oncology, Medicine 2013 - 2015
Recognition
In the News
- AUG 27, 2015
  
  Breast Cancer Risk Score Impacts Use of Chemotherapy
Expertise
Subject Headings
- Health Services
- Population Health
Global Scholarship
- Research
  - United States of America (Country)
Research
Selected Grants
- Disparities in the Use of Oral Anticancer Agents in Kidney Cancer awarded by National Institutes of Health 2019 - 2023
- National Utilization Patterns of Oncotype DX in Early Stage Breast Cancer awarded by Agency for Healthcare Research and Quality 2015 - 2019
- Bladder Cancer in Older Adults - Treatment and Outcomes awarded by AstraZeneca Pharmaceuticals, LP 2016 - 2017
- Thyrogen Utilization Patterns in the Treatment of Thyroid Cancer awarded by Genzyme Corporation 2015 - 2017
- National Utilization Patterns of Oncotype DX in Early Stage Breast Cancer awarded by Agency for Healthcare Research and Quality 2013 - 2015
- Cardiac Imaging awarded by BC Cancer Research Centre 2014 - 2015
Publications & Artistic Works
Selected Publications
- Academic Articles
  - Rotter, Jason, Lauren Wilson, Melissa A. Greiner, Craig E. Pollack, and Michaela Dinan. “Shared-patient physician networks and their impact on the uptake of genomic testing in breast cancer..” Breast Cancer Res Treat, April 26, 2019. https://doi.org/10.1007/s10549-019-05248-2.
    Full Text Link to Item
  - Dinan, Michaela A., Lauren E. Wilson, and Shelby D. Reed. “Chemotherapy Costs and 21-Gene Recurrence Score Genomic Testing Among Medicare Beneficiaries With Early-Stage Breast Cancer, 2005 to 2011..” Journal of the National Comprehensive Cancer Network : Jnccn 17, no. 3 (March 2019): 245–54. https://doi.org/10.6004/jnccn.2018.7097.
    Full Text
  - Dinan, Michaela A., Yanhong Li, Shelby D. Reed, and Julie Ann Sosa. “INITIAL ADOPTION OF RECOMBINANT HUMAN THYROID-STIMULATING HORMONE FOLLOWING THYROIDECTOMY IN THE MEDICARE THYROID CANCER PATIENT POPULATION..” Endocr Pract 25, no. 1 (January 2019): 31–42. https://doi.org/10.4158/EP-2018-0253.
    Full Text Link to Item
  - Ramalingam, Sendhilnathan, Michaela A. Dinan, and Jeffrey Crawford. “Survival Comparison in Patients with Stage IV Lung Cancer in Academic versus Community Centers in the United States..” Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer 13, no. 12 (December 2018): 1842–50. https://doi.org/10.1016/j.jtho.2018.09.007.
    Full Text
  - Dinan, Michaela A., Lesley H. Curtis, Soko Setoguchi, and Winson Y. Cheung. “Advanced imaging and hospice use in end-of-life cancer care..” Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer 26, no. 10 (October 2018): 3619–25. https://doi.org/10.1007/s00520-018-4223-0.
    Full Text
  - Wilson, Lauren E., Craig Evan Pollack, Melissa A. Greiner, and Michaela A. Dinan. “Association between physician characteristics and the use of 21-gene recurrence score genomic testing among Medicare beneficiaries with early-stage breast cancer, 2008-2011..” Breast Cancer Research and Treatment 170, no. 2 (July 2018): 361–71. https://doi.org/10.1007/s10549-018-4746-6.
    Full Text
  - Clough, Jeffrey D., Michaela A. Dinan, and Kevin A. Schulman. “Trends in hospital-physician integration in medical oncology..” The American Journal of Managed Care 23, no. 10 (October 2017): 624–27.
  - Harowicz, Michael R., Timothy J. Robinson, Michaela A. Dinan, Ashirbani Saha, Jeffrey R. Marks, P Kelly Marcom, and Maciej A. Mazurowski. “Algorithms for prediction of the Oncotype DX recurrence score using clinicopathologic data: a review and comparison using an independent dataset..” Breast Cancer Research and Treatment 162, no. 1 (February 2017): 1–10. https://doi.org/10.1007/s10549-016-4093-4.
    Full Text
  - Kim, Edward, Michaela Dinan, Km Monirul Islam, Ancilla Fernandes, Lee Schwartzberg, Elisabeth Croft, Julie Brahmer, et al. “PS01.61: Registry for the EVolution Of LUng Cancer Therapy Implementation and Outcomes Now (REVOLUTION): Registry Study in Progress: Topic: Medical Oncology..” Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer 11, no. 11S (November 2016): S308–9. https://doi.org/10.1016/j.jtho.2016.09.096.
    Full Text
  - Robinson, Timothy J., Samantha Thomas, Michaela A. Dinan, Sanziana Roman, Julie Ann Sosa, and Terry Hyslop. “How Many Lymph Nodes Are Enough? Assessing the Adequacy of Lymph Node Yield for Papillary Thyroid Cancer..” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 34, no. 28 (October 2016): 3434–39. https://doi.org/10.1200/JCO.2016.67.6437.
    Full Text
  - Ruel, Ewa, Samantha Thomas, Michaela A. Dinan, Jennifer M. Perkins, Sanziana A. Roman, and Julie Ann Sosa. “Knowledge of pathologically versus clinically negative lymph nodes is associated with reduced use of radioactive iodine post-thyroidectomy for low-risk papillary thyroid cancer..” Endocrine 52, no. 3 (June 2016): 579–86. https://doi.org/10.1007/s12020-015-0826-0.
    Full Text
  - Roberts, Megan C., Amy Bryson, Morris Weinberger, Stacie B. Dusetzina, Michaela A. Dinan, Katherine E. Reeder-Hayes, and Stephanie B. Wheeler. “Patient-Centered Communication for Discussing Oncotype DX Testing..” Cancer Investigation 34, no. 5 (May 2016): 205–12. https://doi.org/10.3109/07357907.2016.1172637.
    Full Text
  - Cohen, Seth M., Michaela A. Dinan, Jaewhan Kim, and Nelson Roy. “Otolaryngology utilization of speech-language pathology services for voice disorders..” The Laryngoscope 126, no. 4 (April 2016): 906–12. https://doi.org/10.1002/lary.25574.
    Full Text
  - Dinan, Michaela A., Yanhong Li, Yinghong Zhang, Suzanne B. Stewart, Lesley H. Curtis, Daniel J. George, and Shelby D. Reed. “Resource Use in the Last Year of Life Among Patients Who Died With Versus of Prostate Cancer..” Clinical Genitourinary Cancer 14, no. 1 (February 2016): 28-37.e2. https://doi.org/10.1016/j.clgc.2015.07.006.
    Full Text
  - Roberts, Megan C., Amy Bryson, Morris Weinberger, Stacie B. Dusetzina, Michaela A. Dinan, Katherine Reeder-Hayes, and Stephanie B. Wheeler. “ONCOLOGISTS' BARRIERS AND FACILITATORS FOR ONCOTYPE DX USE: QUALITATIVE STUDY..” International Journal of Technology Assessment in Health Care 32, no. 5 (January 2016): 355–61. https://doi.org/10.1017/s026646231600060x.
    Full Text
  - Roberts, Megan C., Morris Weinberger, Stacie B. Dusetzina, Michaela A. Dinan, Katherine E. Reeder-Hayes, Lisa A. Carey, Melissa A. Troester, and Stephanie B. Wheeler. “Racial Variation in the Uptake of Oncotype DX Testing for Early-Stage Breast Cancer..” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 34, no. 2 (January 2016): 130–38. https://doi.org/10.1200/JCO.2015.63.2489.
    Full Text
  - Dinan, Michaela A., Xiaojuan Mi, Shelby D. Reed, Gary H. Lyman, and Lesley H. Curtis. “Association Between Use of the 21-Gene Recurrence Score Assay and Receipt of Chemotherapy Among Medicare Beneficiaries With Early-Stage Breast Cancer, 2005-2009..” Jama Oncology 1, no. 8 (November 2015): 1098–1109. https://doi.org/10.1001/jamaoncol.2015.2722.
    Full Text
  - Adam, Mohamed Abdelgadir, Kingshuk Choudhury, Michaela A. Dinan, Shelby D. Reed, Randall P. Scheri, Dan G. Blazer, Sanziana A. Roman, and Julie A. Sosa. “Minimally Invasive Versus Open Pancreaticoduodenectomy for Cancer: Practice Patterns and Short-term Outcomes Among 7061 Patients..” Ann Surg 262, no. 2 (August 2015): 372–77. https://doi.org/10.1097/SLA.0000000000001055.
    Full Text Link to Item
  - Roberts, Megan C., Morris Weinberger, Stacie B. Dusetzina, Michaela A. Dinan, Katherine E. Reeder-Hayes, Melissa A. Troester, Lisa A. Carey, and Stephanie B. Wheeler. “Racial variation in adjuvant chemotherapy initiation among breast cancer patients receiving oncotype DX testing..” Breast Cancer Research and Treatment 153, no. 1 (August 2015): 191–200. https://doi.org/10.1007/s10549-015-3518-9.
    Full Text
  - Adam, Mohamed Abdelgadir, John Pura, Paolo Goffredo, Michaela A. Dinan, Shelby D. Reed, Randall P. Scheri, Terry Hyslop, Sanziana A. Roman, and Julie A. Sosa. “Presence and Number of Lymph Node Metastases Are Associated With Compromised Survival for Patients Younger Than Age 45 Years With Papillary Thyroid Cancer..” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 33, no. 21 (July 2015): 2370–75. https://doi.org/10.1200/jco.2014.59.8391.
    Full Text
  - Dinan, Michaela A., Xiaojuan Mi, Shelby D. Reed, Bradford R. Hirsch, Gary H. Lyman, and Lesley H. Curtis. “Initial Trends in the Use of the 21-Gene Recurrence Score Assay for Patients With Breast Cancer in the Medicare Population, 2005-2009..” Jama Oncology 1, no. 2 (May 2015): 158–66. https://doi.org/10.1001/jamaoncol.2015.43.
    Full Text
  - Havrilesky, L. J., M. Dinan, G. P. Sfakianos, L. H. Curtis, J. C. Barnett, T. Van Gorp, and E. R. Myers. “Costs, effectiveness, and workload impact of management strategies for women with an adnexal mass.” Obstetrical and Gynecological Survey 70, no. 4 (April 22, 2015): 253–55. https://doi.org/10.1097/01.ogx.0000464937.42384.2d.
    Full Text
  - Ruel, Ewa, Samantha Thomas, Michaela Dinan, Jennifer M. Perkins, Sanziana A. Roman, and Julie Ann Sosa. “Adjuvant radioactive iodine therapy is associated with improved survival for patients with intermediate-risk papillary thyroid cancer..” The Journal of Clinical Endocrinology and Metabolism 100, no. 4 (April 2015): 1529–36. https://doi.org/10.1210/jc.2014-4332.
    Full Text
  - Adam, M. A., J. Pura, P. Goffredo, M. A. Dinan, T. Hyslop, S. D. Reed, R. P. Scheri, S. A. Roman, and J. A. Sosa. “Impact of extent of surgery on survival for papillary thyroid cancer patients younger than 45 years.” Journal of Clinical Endocrinology and Metabolism 100, no. 1 (2015): 115–21. https://doi.org/10.1210/jc.20143039.
    Full Text
  - Adam, Mohamed Abdelgadir, John Pura, Paolo Goffredo, Michaela A. Dinan, Terry Hyslop, Shelby D. Reed, Randall P. Scheri, Sanziana A. Roman, and Julie A. Sosa. “Impact of extent of surgery on survival for papillary thyroid cancer patients younger than 45 years..” The Journal of Clinical Endocrinology and Metabolism 100, no. 1 (January 2015): 115–21. https://doi.org/10.1210/jc.2014-3039.
    Full Text
  - Dinan, Michaela A., Bradford R. Hirsch, and Gary H. Lyman. “Management of chemotherapy-induced neutropenia: measuring quality, cost, and value..” Journal of the National Comprehensive Cancer Network : Jnccn 13, no. 1 (January 2015): e1–7. https://doi.org/10.6004/jnccn.2015.0014.
    Full Text
  - Havrilesky, Laura J., Michaela Dinan, Gregory P. Sfakianos, Lesley H. Curtis, Jason C. Barnett, Toon Van Gorp, and Evan R. Myers. “Costs, effectiveness, and workload impact of management strategies for women with an adnexal mass..” J Natl Cancer Inst 107, no. 1 (January 2015). https://doi.org/10.1093/jnci/dju322.
    Full Text Link to Item
  - Dinan, Michaela A., and Kevin A. Schulman. “Exploring variation in care: alternative conceptual models..” Annals of Internal Medicine 161, no. 11 (December 2014): 835–36. https://doi.org/10.7326/m14-2382.
    Full Text
  - Adam, Mohamed Abdelgadir, Paul Speicher, John Pura, Michaela A. Dinan, Shelby D. Reed, Sanziana A. Roman, and Julie A. Sosa. “Robotic thyroidectomy for cancer in the US: patterns of use and short-term outcomes..” Annals of Surgical Oncology 21, no. 12 (November 2014): 3859–64. https://doi.org/10.1245/s10434-014-3838-8.
    Full Text
  - Adam, Mohamed Abdelgadir, John Pura, Lin Gu, Michaela A. Dinan, Douglas S. Tyler, Shelby D. Reed, Randall Scheri, Sanziana A. Roman, and Julie A. Sosa. “Extent of surgery for papillary thyroid cancer is not associated with survival: an analysis of 61,775 patients..” Annals of Surgery 260, no. 4 (October 2014): 601–5. https://doi.org/10.1097/SLA.0000000000000925.
    Full Text
  - Gratian, Lauren, John Pura, Michaela Dinan, Sanziana Roman, Shelby Reed, and Julie Ann Sosa. “Impact of extent of surgery on survival in patients with small nonfunctional pancreatic neuroendocrine tumors in the United States..” Annals of Surgical Oncology 21, no. 11 (October 2014): 3515–21. https://doi.org/10.1245/s10434-014-3769-4.
    Full Text
  - Gratian, Lauren, John Pura, Michaela Dinan, Shelby Reed, Randall Scheri, Sanziana Roman, and Julie Ann Sosa. “Treatment patterns and outcomes for patients with adrenocortical carcinoma associated with hospital case volume in the United States..” Annals of Surgical Oncology 21, no. 11 (October 2014): 3509–14. https://doi.org/10.1245/s10434-014-3931-z.
    Full Text
  - Dinan, Michaela A., Lesley H. Curtis, William R. Carpenter, Andrea K. Biddle, Amy P. Abernethy, Edward F. Patz, Kevin A. Schulman, and Morris Weinberger. “Redistribution of health care costs after the adoption of positron emission tomography among medicare beneficiaries with non-small-cell lung cancer, 1998-2005..” Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer 9, no. 4 (April 2014): 512–18. https://doi.org/10.1097/jto.0000000000000102.
    Full Text
  - Abdelgadir Adam, M., P. Speicher, J. Pura, M. A. Dinan, S. D. Reed, S. A. Roman, and J. A. Sosa. “Robotic Thyroidectomy for Cancer in the US: Patterns of Use and Short-Term Outcomes.” Annals of Surgical Oncology 21, no. 12 (January 1, 2014): 3859–64. https://doi.org/10.1245/s10434-014-3838-8.
    Full Text
  - Cohen, Seth M., Michaela A. Dinan, Nelson Roy, Jaewhan Kim, and Mark Courey. “Diagnosis change in voice-disordered patients evaluated by primary care and/or otolaryngology: a longitudinal study..” Otolaryngology Head and Neck Surgery : Official Journal of American Academy of Otolaryngology Head and Neck Surgery 150, no. 1 (January 2014): 95–102. https://doi.org/10.1177/0194599813512982.
    Full Text
  - Gratian, L., J. Pura, M. Dinan, S. Reed, R. Scheri, S. Roman, and J. A. N. Sosa. “Treatment patterns and outcomes for patients with adrenocortical carcinoma associated with hospital case volume in the United States.” Annals of Surgical Oncology 21, no. 11 (2014): 3509–14. https://doi.org/10.1245/s10434-014-3931-z.
    Full Text
  - Gratian, L., J. Pura, M. Dinan, S. Roman, S. Reed, and J. A. N. Sosa. “Impact of extent of surgery on survival in patients with small nonfunctional pancreatic neuroendocrine tumors in the United States.” Annals of Surgical Oncology 21, no. 11 (2014): 3515–21. https://doi.org/10.1245/s10434-014-3769-4.
    Full Text
  - Moorman, Patricia G., Laura J. Havrilesky, Jennifer M. Gierisch, Remy R. Coeytaux, William J. Lowery, Rachel Peragallo Urrutia, Michaela Dinan, et al. “Oral contraceptives and risk of ovarian cancer and breast cancer among high-risk women: a systematic review and meta-analysis..” J Clin Oncol 31, no. 33 (November 20, 2013): 4188–98. https://doi.org/10.1200/JCO.2013.48.9021.
    Full Text Link to Item
  - Gierisch, Jennifer M., Remy R. Coeytaux, Rachel Peragallo Urrutia, Laura J. Havrilesky, Patricia G. Moorman, William J. Lowery, Michaela Dinan, et al. “Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review..” Cancer Epidemiology, Biomarkers & Prevention : A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology 22, no. 11 (November 2013): 1931–43. https://doi.org/10.1158/1055-9965.epi-13-0298.
    Full Text
  - Peragallo Urrutia, Rachel, Remy R. Coeytaux, Amanda J. McBroom, Jennifer M. Gierisch, Laura J. Havrilesky, Patricia G. Moorman, William J. Lowery, et al. “Risk of acute thromboembolic events with oral contraceptive use: a systematic review and meta-analysis..” Obstetrics and Gynecology 122, no. 2 Pt 1 (August 2013): 380–89. https://doi.org/10.1097/aog.0b013e3182994c43.
    Full Text
  - Havrilesky, Laura J., Patricia G. Moorman, William J. Lowery, Jennifer M. Gierisch, Remy R. Coeytaux, Rachel Peragallo Urrutia, Michaela Dinan, et al. “Oral contraceptive pills as primary prevention for ovarian cancer: a systematic review and meta-analysis..” Obstet Gynecol 122, no. 1 (July 2013): 139–47. https://doi.org/10.1097/AOG.0b013e318291c235.
    Full Text Link to Item
  - Dinan, Michaela A., Lesley H. Curtis, William R. Carpenter, Andrea K. Biddle, Amy P. Abernethy, Edward F. Patz, Kevin A. Schulman, and Morris Weinberger. “Variations in use of PET among Medicare beneficiaries with non-small cell lung cancer, 1998-2007..” Radiology 267, no. 3 (June 2013): 807–17. https://doi.org/10.1148/radiol.12120174.
    Full Text
  - Havrilesky, Laura J., Jennifer M. Gierisch, Patricia G. Moorman, Remy R. Coeytaux, Rachel Peragallo Urrutia, William J. Lowery, Michaela Dinan, et al. “Oral contraceptive use for the primary prevention of ovarian cancer..” Evidence Report/Technology Assessment, no. 212 (June 2013): 1–514.
  - Reed, Shelby D., Michaela A. Dinan, Kevin A. Schulman, and Gary H. Lyman. “Cost-effectiveness of the 21-gene recurrence score assay in the context of multifactorial decision making to guide chemotherapy for early-stage breast cancer..” Genetics in Medicine : Official Journal of the American College of Medical Genetics 15, no. 3 (March 2013): 203–11. https://doi.org/10.1038/gim.2012.119.
    Full Text
  - Dinan, Michaela A., William R. Carpenter, Edward F. Patz, Amy P. Abernethy, Andrea K. Biddle, Kevin A. Schulman, and Lesley H. Curtis. “Reply to M.S. Hofman et al..” J Clin Oncol 31, no. 6 (February 20, 2013). https://doi.org/10.1200/JCO.2012.46.7373.
    Full Text Link to Item
  - Havrilesky, L. J., P. G. Moorman, W. J. Lowery, J. M. Gierisch, R. R. Coeytaux, R. P. Urrutia, M. Dinan, et al. “Oral contraceptive pills as primary prevention for ovarian cancer: A systematic review and meta-analysis.” Obstetrics and Gynecology 122, no. 1 (2013): 139–47. https://doi.org/10.1097/AOG.0b013e318291c235.
    Full Text
  - Peragallo Urrutia, R., R. R. Coeytaux, A. J. McBroom, J. M. Gierisch, L. J. Havrilesky, P. G. Moorman, W. J. Lowery, et al. “Risk of acute thromboembolic events with oral contraceptive use: a systematic review and meta-analysis..” Obstetrics and Gynecology 122, no. 2 Pt 1 (January 1, 2013): 380–89.
  - Dinan, Michaela A., Lesley H. Curtis, William R. Carpenter, Andrea K. Biddle, Amy P. Abernethy, Edward F. Patz, Kevin A. Schulman, and Morris Weinberger. “Stage migration, selection bias, and survival associated with the adoption of positron emission tomography among medicare beneficiaries with non-small-cell lung cancer, 1998-2003..” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 30, no. 22 (August 2012): 2725–30. https://doi.org/10.1200/jco.2011.40.4392.
    Full Text
  - Dinan, Michaela A., Timothy J. Robinson, Timothy M. Zagar, Charles D. Scales, Lesley H. Curtis, Shelby D. Reed, W Robert Lee, and Kevin A. Schulman. “Changes in initial treatment for prostate cancer among Medicare beneficiaries, 1999-2007..” International Journal of Radiation Oncology, Biology, Physics 82, no. 5 (April 2012): e781–86. https://doi.org/10.1016/j.ijrobp.2011.11.024.
    Full Text
  - Dewitt, Esi Morgan, Chelsea A. Grussemeyer, Joëlle Y. Friedman, Michaela A. Dinan, Li Lin, Kevin A. Schulman, and Shelby D. Reed. “Resource use, costs, and utility estimates for patients with cystic fibrosis with mild impairment in lung function: analysis of data collected alongside a 48-week multicenter clinical trial..” Value in Health : The Journal of the International Society for Pharmacoeconomics and Outcomes Research 15, no. 2 (March 2012): 277–83. https://doi.org/10.1016/j.jval.2011.11.027.
    Full Text
  - Simmons, Leigh Ann, Michaela Ann Dinan, Timothy John Robinson, and Ralph Snyderman. “Personalized medicine is more than genomic medicine: confusion over terminology impedes progress towards personalized healthcare..” Personalized Medicine 9, no. 1 (January 2012): 85–91. https://doi.org/10.2217/pme.11.86.
    Full Text
  - Dinan, M. A., C. H. Chou, B. G. Hammill, F. L. Graham, K. A. Schulman, M. J. Telen, and S. D. Reed. “Erratum: Outcomes of inpatients with and without sickle cell disease after high-volume surgical procedures.” American Journal of Hematology 86, no. 10 (October 1, 2011): 906–8. https://doi.org/10.1002/ajh.22120.
    Full Text
  - Kamble, S., M. J. Telen, M. A. Dinan, C. A. Grussemeyer, and S. D. Reed. “Erratum: Costs and length of stay for patients with and without sickle cell disease after hysterectomy, appendectomy, or knee replacement.” American Journal of Hematology 86, no. 10 (October 1, 2011). https://doi.org/10.1002/ajh.22121.
    Full Text
  - Dinan, M. A., T. J. Robinson, T. M. Zagar, C. D. Scales, L. H. Curtis, S. D. Reed, K. A. Schulman, and W. R. Lee. “Financial implications of changes in the initial treatment of prostate cancer among Medicare beneficiaries..” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 29, no. 15_suppl (May 2011).
  - Dinan, Michaela A., Kate L. Compton, Jatinder K. Dhillon, Bradley G. Hammill, Esi Morgan Dewitt, Kevin P. Weinfurt, and Kevin A. Schulman. “Use of patient-reported outcomes in randomized, double-blind, placebo-controlled clinical trials..” Medical Care 49, no. 4 (April 2011): 415–19. https://doi.org/10.1097/MLR.0b013e3182064aa2.
    Full Text
  - Dinan, M. A., K. L. Compton, J. K. Dhillon, B. G. Hammill, E. M. de Witt, K. P. Weinfurt, and K. A. Schulman. “Use of patient-reported outcomes in randomized, double-blind, placebo-controlled clinical trials.” Medical Care, March 1, 2011. https://doi.org/10.1097/MLR.0b013e3182064aa2.
    Full Text
  - Dinan, M. A., K. L. Compton, J. K. Dhillon, B. G. Hammill, E. M. DeWitt, K. P. Weinfurt, and K. A. Schulman. “Use of patient-reported outcomes in randomized, double-blind, placebo-controlled clinical trials.” Medical Care 49, no. 4 (January 1, 2011): 415–19. https://doi.org/10.1097/MLR.0b013e3182064aa2.
    Full Text
  - Dinan, Michaela A., Leigh Ann Simmons, and Ralph Snyderman. “Commentary: Personalized health planning and the Patient Protection and Affordable Care Act: an opportunity for academic medicine to lead health care reform..” Academic Medicine 85, no. 11 (November 2010): 1665–68. https://doi.org/10.1097/acm.0b013e3181f4ab3c.
    Full Text
  - Dinan, Michaela A., Lesley H. Curtis, Bradley G. Hammill, Edward F. Patz, Amy P. Abernethy, Alisa M. Shea, and Kevin A. Schulman. “Changes in the use and costs of diagnostic imaging among Medicare beneficiaries with cancer, 1999-2006..” Jama 303, no. 16 (April 2010): 1625–31. https://doi.org/10.1001/jama.2010.460.
    Full Text
  - Robinson, Timothy J., Michaela A. Dinan, Mark Dewhirst, Mariano A. Garcia-Blanco, and James L. Pearson. “SplicerAV: a tool for mining microarray expression data for changes in RNA processing..” Bmc Bioinformatics 11 (February 25, 2010). https://doi.org/10.1186/1471-2105-11-108.
    Full Text Open Access Copy
  - Kamble, Shital, Marilyn J. Telen, Michaela A. Dinan, Chelsea A. Grussemeyer, and Shelby D. Reed. “Costs and length of stay for patients with and without sickle cell disease after hysterectomy, appendectomy, or knee replacement..” American Journal of Hematology 85, no. 1 (January 2010): 79–81. https://doi.org/10.1002/ajh.21576.
    Full Text
  - Snyderman, Ralph, and Michaela A. Dinan. “Improving health by taking it personally..” Jama 303, no. 4 (January 2010): 363–64. https://doi.org/10.1001/jama.2010.34.
    Full Text
  - Dinan, Michaela A., Chia-Hung Chou, Bradley G. Hammill, Felicia L. Graham, Kevin A. Schulman, Marilyn J. Telen, and Shelby D. Reed. “Outcomes of inpatients with and without sickle cell disease after high-volume surgical procedures..” American Journal of Hematology 84, no. 11 (November 2009): 703–9. https://doi.org/10.1002/ajh.21520.
    Full Text
  - Dinan, M., E. Morgan Dewitt, C. Grussemeyer, and S. D. Reed. “CO4 COMPARISON OF INPATIENT COST ESTIMATION METHODS: USING DATA FROM A CYSTIC FIBROSIS TRIAL.” Value in Health 12, no. 3 (May 2009): A7–A7. https://doi.org/10.1016/s1098-3015(10)73094-1.
    Full Text
  - Weinfurt, Kevin P., Mark A. Hall, Michaela A. Dinan, Venita DePuy, Joëlle Y. Friedman, Jennifer S. Allsbrook, and Jeremy Sugarman. “Effects of disclosing financial interests on attitudes toward clinical research..” Journal of General Internal Medicine 23, no. 6 (June 2008): 860–66. https://doi.org/10.1007/s11606-008-0590-4.
    Full Text
  - Friedman, Joëlle Y., Jeremy Sugarman, Jatinder K. Dhillon, Venita Depuy, Christine K. Pierre, Michaela A. Dinan, Jennifer S. Allsbrook, Kevin A. Schulman, and Kevin P. Weinfurt. “Perspectives of clinical research coordinators on disclosing financial conflicts of interest to potential research participants..” Clinical Trials (London, England) 4, no. 3 (January 2007): 272–78. https://doi.org/10.1177/1740774507079239.
    Full Text
  - Weinfurt, Kevin P., Jennifer S. Allsbrook, Joëlle Y. Friedman, Michaela A. Dinan, Mark A. Hall, Kevin A. Schulman, and Jeremy Sugarman. “Developing model language for disclosing financial interests to potential clinical research participants..” Irb 29, no. 1 (January 2007): 1–5.
  - Dinan, Michaela A., Kevin P. Weinfurt, Joëlle Y. Friedman, Jennifer S. Allsbrook, Julie Gottlieb, Kevin A. Schulman, Mark A. Hall, Jatinder K. Dhillon, and Jeremy Sugarman. “Comparison of conflict of interest policies and reported practices in academic medical centers in the United States..” Accountability in Research 13, no. 4 (October 2006): 325–42. https://doi.org/10.1080/08989620601003414.
    Full Text
  - Weinfurt, Kevin P., Joëlle Y. Friedman, Jennifer S. Allsbrook, Michaela A. Dinan, Mark A. Hall, and Jeremy Sugarman. “Views of potential research participants on financial conflicts of interest: barriers and opportunities for effective disclosure..” Journal of General Internal Medicine 21, no. 9 (September 2006): 901–6. https://doi.org/10.1111/j.1525-1497.2006.00502.x.
    Full Text
  - Weinfurt, K. P., J. Y. Friedman, J. S. Allsbrook, M. A. Dinan, M. A. Hall, and J. Sugarman. “Views of potential research participants on financial conflicts of interest: Barriers and opportunities for effective disclosure.” Journal of General Internal Medicine 21 (April 1, 2006): 160–160.
    Link to Item
  - Weinfurt, K. P., M. A. Hall, M. A. Dinan, V. Depuy, J. Y. Friedman, J. S. Allsbrook, and J. Sugarman. “The effects of disclosing financial conflicts of interest in clinical research: Evidence from a large national survey.” Journal of General Internal Medicine 21 (April 1, 2006): 142–142.
    Link to Item
  - Weinfurt, K. P., M. A. Hall, M. A. Dinan, V. Depuy, J. Y. Friedman, J. S. Allsbrook, and J. Sugarman. “What is necessary to support informed decision making regarding financial conflicts of interests in research?.” Journal of General Internal Medicine 21 (April 1, 2006): 164–164.
    Link to Item
  - Weinfurt, Kevin P., Michaela A. Dinan, Jennifer S. Allsbrook, Joëlle Y. Friedman, Mark A. Hall, Kevin A. Schulman, and Jeremy Sugarman. “Policies of academic medical centers for disclosing financial conflicts of interest to potential research participants..” Academic Medicine 81, no. 2 (February 2006): 113–18. https://doi.org/10.1097/00001888-200602000-00003.
    Full Text
  - Weinfurt, Kevin P., Joëlle Y. Friedman, Michaela A. Dinan, Jennifer S. Allsbrook, Mark A. Hall, Jatinder K. Dhillon, and Jeremy Sugarman. “Disclosing conflicts of interest in clinical research: views of institutional review boards, conflict of interest committees, and investigators..” The Journal of Law, Medicine & Ethics : A Journal of the American Society of Law, Medicine & Ethics 34, no. 3 (January 2006): 581–481. https://doi.org/10.1111/j.1748-720x.2006.00072.x.
    Full Text
- Other Articles
  - Goffredo, Paolo, Samantha M. Thomas, Michaela A. Dinan, Jennifer M. Perkins, Sanziana A. Roman, and Julie A. Sosa. “Patterns of use and cost for inappropriate radioactive iodine treatment for thyroid cancer in the United States: use and misuse..” Jama Internal Medicine, April 2015. https://doi.org/10.1001/jamainternmed.2014.8020.
    Full Text
- Conference Papers
  - Georgieva, M., J. L. Lund, M. E. Nielsen, J. Trogdon, M. A. Dinan, M. Weinberger, and S. B. Wheeler. “The Impact of Functional Status and Multi-Morbidity On Surveillance Use Among Medicare Beneficiaries with Bladder Cancer.” In Value in Health, 21:S141–S141. Elsevier BV, 2018. https://doi.org/10.1016/j.jval.2018.04.951.
    Full Text
  - Hanlon, Ashley, Steven Fleming, Ann S. Hamilton, Michaela Ann Dinan, Chiara Melloni, Michael Roger Harrison, Michel Khouri, et al. “Androgen deprivation therapy (ADT) and cardiovascular mortality (CVD) in men with early-stage prostate cancer (PC) receiving curative radiation therapy (RT)..” In Journal of Clinical Oncology, 36:127–127. American Society of Clinical Oncology (ASCO), 2018. https://doi.org/10.1200/jco.2018.36.7_suppl.127.
    Full Text
  - Dinan, Michaela Ann, Mihaela Georgieva, Rahul Shenolikar, and Charles D. Scales. “Real-world systemic therapy utilization in Medicare patients with locally advanced or metastatic urothelial carcinoma..” In Journal of Clinical Oncology, 36:415–415. American Society of Clinical Oncology (ASCO), 2018. https://doi.org/10.1200/jco.2018.36.6_suppl.415.
    Full Text
  - Dinan, Michaela A., Lauren E. Wilson, Melissa Greiner, and Craig E. Pollack. “Provider characteristics and receipt of oncotype Dx testing in women diagnosed with early stage breast cancer using SEER-Medicare data.” In Cancer Research, Vol. 78. AMER ASSOC CANCER RESEARCH, 2018.
    Link to Item
  - Ramalingam, S., M. Dinan, and J. Crawford. “4B.02 Increasing Survival in Stage IV NSCLC in Academic versus Community Based Centers in the National Cancer Database.” In Journal of Thoracic Oncology, 12:S1560–S1560. Elsevier BV, 2017. https://doi.org/10.1016/j.jtho.2017.09.029.
    Full Text
  - Savla, B., K. A. Ahmed, M. Yu, B. A. Perez, M. A. Dinan, N. Mason, and T. J. Robinson. “Use of Whole Brain Radiation Therapy and Immune Checkpoint Inhibition in the Management of Brain Metastases.” In International Journal of Radiation Oncology*Biology*Physics, 99:E105–E105. Elsevier BV, 2017. https://doi.org/10.1016/j.ijrobp.2017.06.842.
    Full Text
  - Kim, Edward, Michaela Dinan, KM Monirul Islam, Ancilla Fernandes, Lee Schwartzberg, Elisabeth Croft, Julie Brahmer, et al. “Registry for the EVolution Of LUng Cancer Therapy Implementation and Outcomes Now (REVOLUTION): Registry Study in Progress.” In Journal of Thoracic Oncology, 11:S308–9. ELSEVIER SCIENCE INC, 2016.
    Link to Item
  - Dinan, Michaela Ann, Xiaojuan Mi, Shelby D. Reed, Gary H. Lyman, and Lesley H. Curtis. “Chemotherapy costs associated with receipt of the adoption of oncotype DX in early-stage breast cancer within the SEER-Medicare population..” In Journal of Clinical Oncology, 34:32–32. American Society of Clinical Oncology (ASCO), 2016. https://doi.org/10.1200/jco.2016.34.7_suppl.32.
    Full Text
  - Dinan, M. A., Y. Li, S. Reed, and W. Cheung. “Nationwide Utilization of Cardiac Imaging in Patients Undergoing External Beam Radiation Therapy With and Without Cardiotoxic Chemotherapy.” In International Journal of Radiation Oncology*Biology*Physics, 93:E368–69. Elsevier BV, 2015. https://doi.org/10.1016/j.ijrobp.2015.07.1487.
    Full Text
  - Robinson, Timothy J., Michaela A. Dinan, Yanhong Li, W Robert Lee, and Shelby D. Reed. “Longitudinal Trends in Costs of Palliative Radiation for Metastatic Prostate Cancer..” In Journal of Palliative Medicine, 18:933–39, 2015. https://doi.org/10.1089/jpm.2015.0171.
    Full Text
  - Dinan, Michaela Ann, Yanhong Li, Shelby D. Reed, and Winson Y. Cheung. “Nationwide utilization of cardiac imaging in patients undergoing cardiotoxic chemotherapy..” In Journal of Clinical Oncology, 33:6592–6592. American Society of Clinical Oncology (ASCO), 2015. https://doi.org/10.1200/jco.2015.33.15_suppl.6592.
    Full Text
  - Dinan, M., L. Havrilesky, and E. Myers. “Relative Incidence of Uterine Sarcoma and Surgical Treatments for Fibroids.” In Annals of Surgical Oncology, 22:S132–33. SPRINGER, 2015.
    Link to Item
  - Dinan, M. A., L. Curtis, S. Setoguchi-Iwata, and W. Cheung. “Association Between Diagnostic CT Utilization and Radiation Therapy at the End of Life (EOL) in Elderly Breast and Prostate Cancer Patients: 2002-2007.” In International Journal of Radiation Oncology*Biology*Physics, 90:S582–S582. Elsevier BV, 2014. https://doi.org/10.1016/j.ijrobp.2014.05.1751.
    Full Text
  - Palta, M., B. G. Czito, C. G. Willett, and M. A. Dinan. “Intensity Modulated Radiation Therapy Utilization in the Treatment of Gastrointestinal Malignancies Between 2000 and 2009 in the SEER-Medicare Population.” In International Journal of Radiation Oncology*Biology*Physics, 90:S401–2. Elsevier BV, 2014. https://doi.org/10.1016/j.ijrobp.2014.05.1281.
    Full Text
  - Dinan, Michaela Ann, Lesley H. Curtis, Soko Setoguchi, and Winson Y. Cheung. “Association between CT utilization and radiation therapy at the end of life (EOL) in elderly breast and prostate cancer patients..” In Journal of Clinical Oncology, 32:6529–6529. American Society of Clinical Oncology (ASCO), 2014. https://doi.org/10.1200/jco.2014.32.15_suppl.6529.
    Full Text
  - Dinan, Michaela Ann, Xiaojuan Mi, Shelby D. Reed, Bradford Richard Hirsch, Gary H. Lyman, and Lesley H. Curtis. “Initial utilization of Oncotype DX in the Medicare population between 2005 and 2007..” In Journal of Clinical Oncology, 32:6508–6508. American Society of Clinical Oncology (ASCO), 2014. https://doi.org/10.1200/jco.2014.32.15_suppl.6508.
    Full Text
  - Dinan, M. A., L. H. Curtis, W. R. Carpenter, A. K. Biddle, A. P. Abernethy, E. F. Patz, K. A. Schulman, and M. Weinberger. “Changes in Radiation Therapy, Surgery, and Costs for Treatment of Non-Small Cell Lung Cancer After the Adoption of Positron Emission Tomography: 1998-2005.” In International Journal of Radiation Oncology*Biology*Physics, 87:S41–42. Elsevier BV, 2013. https://doi.org/10.1016/j.ijrobp.2013.06.110.
    Full Text
  - Dinan, Michaela A., Soko Setoguchi, Lesley H. Curtis, and Winson Y. Cheung. “Association between high-cost imaging and hospice use at the end of life of cancer patients..” In Journal of Clinical Oncology, Vol. 31. AMER SOC CLINICAL ONCOLOGY, 2013.
    Link to Item
  - Reed, Shelby D., Michaela A. Dinan, Yanhong Li, Yinghong Zhang, Lesley H. Curtis, Daniel J. George, and Suzanne B. Stewart. “Resource use and costs in the last year of life among Medicare beneficiaries who died from prostate cancer versus with the disease between 2000 and 2007..” In Journal of Clinical Oncology, Vol. 31. AMER SOC CLINICAL ONCOLOGY, 2013.
    Link to Item
  - Robinson, Timothy J., Michaela A. Dinan, Yanhong Li, Robert Lee, and Shelby D. Reed. “Longitudinal trends in costs for palliative radiation for metastatic prostate cancer.” In Journal of Clinical Oncology, Vol. 31. AMER SOC CLINICAL ONCOLOGY, 2013.
    Link to Item
  - Reed, Shelby D., Michaela A. Dinan, Kevin A. Schulman, and Gary H. Lyman. “Cost-effectiveness of the 21-gene recurrence score assay in the setting of multifactorial decision making for chemotherapy in early-stage breast cancer.” In Journal of Clinical Oncology, Vol. 30. AMER SOC CLINICAL ONCOLOGY, 2012.
    Link to Item
  - Dinan, M. A., T. J. Robinson, T. M. Zagar, C. D. Scales, L. H. Curtis, S. D. Reed, K. A. Schulman, and W. R. Lee. “Financial implications of changes in the initial treatment of prostate cancer among Medicare beneficiaries..” In Journal of Clinical Oncology, 29:6115–6115. American Society of Clinical Oncology (ASCO), 2011. https://doi.org/10.1200/jco.2011.29.15_suppl.6115.
    Full Text

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.

Education, Training, & Certifications

Duke Appointment History

In the News

Subject Headings

Global Scholarship

Research

Selected Grants

Selected Publications

Academic Articles

Other Articles

Conference Papers